NCT06680583 Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding
| NCT ID | NCT06680583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Martin De Porress Hospital |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2027-03-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-11-01 with a primary completion date of 2027-03-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Can physiological indicators such as quick Sequential Organ Failure Assessment , Shock Index, and its derived indicators such as Modified Shock Index , Age Shock Index and Respiratory Adjusted Shock Index accurately predict the prognosis of cirrhosis patients with gastrointestinal bleeding? To explore the improvement of emergency and critical care patient management.
Eligibility Criteria
Inclusion Criteria: cirrhosis with gastrointestinal bleeding - Exclusion Criteria: no complete medical record and trauma patient \-
Contact & Investigator
Yeong-Chin Jou Jou, professor
STUDY DIRECTOR
St. Martin De Porres Hospital Education and Research
Frequently Asked Questions
Who can join the NCT06680583 clinical trial?
This trial is open to participants of all sexes, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06680583 currently recruiting?
Yes, NCT06680583 is actively recruiting participants. Contact the research team at urologist3509@gmail.com for enrollment information.
Where is the NCT06680583 trial being conducted?
This trial is being conducted at Tainan, Taiwan.
Who is sponsoring the NCT06680583 clinical trial?
NCT06680583 is sponsored by St. Martin De Porress Hospital. The principal investigator is Yeong-Chin Jou Jou, professor at St. Martin De Porres Hospital Education and Research. The trial plans to enroll 150 participants.